A new study to be published in an upcoming edition of the journal of Diabetes Research and Clinical Practice reveals that French maritime pine tree extract known as Pycnogenol? (pic-noj-en-all) delays the uptake of glucose from a meal 190 times more than prescription medications, preventing the typical high-glucose peak in the blood stream after a meal.
More than 7,000 deaths and 27,000 cardiovascular events, such as heart attacks, can be avoided over the next five years by modernising the prevention and treatment of coronary heart disease (CHD), the Scottish Intercollegiate Guidelines Network (SIGN) said.
Cancer services in Wales are over-stretched and over-complicated, according to a new report by the UK assembly health committee review, that also found confusion within the NHS when it comes to planning and funding care.
A new computer-based technique could eliminate hours of manual adjustment associated with a popular cancer treatment.
Opioid therapy, opioid prescribing and prescription drug diversion are provoking topics at the 23rd annual meeting of the American Academy of Pain Medicine (AAPM) at the Hilton New Orleans Riverside Hotel/Morial Convention Center, Feb. 7-10, 2007.
Medical authorities hope the cholera outbreak in the Republic of Congo has been contained as no more deaths have been reported since Sunday.
Treatment with low doses of levetiracetam, the active ingredient in the drug Keppra, appears to be effective by itself for controlling newly diagnosed epilepsy, new research indicates.
The U.S. Food and Drug Administration (FDA) today cleared for marketing a test that determines the likelihood of breast cancer returning within five to 10 years after a woman’s initial cancer.
An analysis of data from four clinical trials suggests that statin therapy is associated with regression of coronary atherosclerosis when low-density lipoprotein cholesterol (LDL-C or “bad” cholesterol) is substantially reduced and high-density lipoprotein cholesterol (HDL-C or “good” cholesterol) is increased, but it remains to be determined whether this degree of atherosclerosis regression will translate to meaningful reductions in cardiovascular events, according to a study published in the Feb. 7 issue of JAMA.
Women with breast cancer who receive compounds that stimulate white blood cell production to help their bodies better tolerate chemotherapy are at an increased risk of developing a type of leukemia or a condition called myelodysplastic syndrome, according to a new study in the February 7, Journal of the National Cancer Institute.